FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NIROGACESTAT
异名/同义词(2S)-2-(((2S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRO-2-NAPHTHALENYL)AMINO)-N-(1-(2-((2,2-DIMETHYLPROPYL)AMINO)-1,1-DIMETHYLETHYL)-1H-IMIDAZOL-4-YL)PENTANAMIDE
(S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE
NIROGACESTAT
NIROGACESTAT [INN]
NIROGACESTAT [USAN]
NIROGACESTAT [WHO-DD]
PENTANAMIDE, 2-(((2S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRO-2-NAPHTHALENYL)AMINO)-N-(1-(2-((2,2-DIMETHYLPROPYL)AMINO)-1,1-DIMETHYLETHYL)-1H-IMIDAZOL-4-YL)-, (2S)-
PF 03084014
PF 3084014
PF-03084014
PF-3084014
CAS登记号1290543-63-3
物质唯一标识(Unique Ingredient Identifier)QZ62892OFJ
分子式C27H41F2N5O
国际化合物标识(International Chemical Identifier,InChI)VFCRKLWBYMDAED-REWPJTCUSA-N
SMILESc1c(cc2c(c1F)C[C@H](CC2)N[C@H](C(Nc3cn(cn3)C(CNCC(C)(C)C)(C)C)=O)CCC)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System